// App-Quantinova.ai

: Study of target tissue-resident immune cells in graves’ disease and orbitopathy (star-GO): preliminary findings with a novel extensive immunophenotyping panel

Researchers

Presenter

  • Sara Maioli

Principal Investigators

  • Mario Salvi

  • Giorgia Moschetti

  • Mariacristina Crosti

  • Erica Crivicich

  • Francesco Di Marco

  • Nicola Currò

  • Alessia Dolci

  • Maura Arosio

  • Giovanna Mantovani

  • Colin Dayan

  • Jens Geginat

  • Ilaria Muller

Medical Centers

  • Department of Clinical Sciences and Community Health, University of Milan, Italy

  • Thyroid Research Group, School of Medicine, Cardiff University, Cardiff, United Kingdom

  • Fondazione Irccs Ca’ Granda Policlinico Hospital of Milan, Clinical Sciences and Community Health

  • Ophthalmology, Fondazione Irccs Cà Granda, Ospedale Maggiore Policlinico, Italy

  • Graves Orbitopathy Centre, Endocrine

  • Graves’ Orbitopathy Centre, Milan, Italy

  • GravesÂ’ Orbitopathy Centre, Fondazione IRCCS Cà Granda and University of Milan, Milan, Italy

  • Fondazione Irccs Ca’ Granda, University of Milan, University of Milan, Milan, Italy

  • University of Milan, Fondazione Irccs Ca’ Granda, Clinical Sciences and Community Health, Milano, Italy

  • Graves’ Orbitopathy Centre, Endocrinology Department, Fondazione Irccs Ca’ Granda, University of Milan, University of Milan, Clinical Sciences and Community Health, Milan, Italy, Milan, Italy

  • Enocrinology

  • Endocrinology, Fondazione Irccs Cà Granda, Ospedale Maggiore Policlinico

  • University of Milan

  • National Institute of Molecular Genetics, Milan, Italy

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Autoimmune Thyroid Disease

Biomarkers

  • N/A

Drug/Treatment

  • Thyrotropin alfa

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved